https://www.selleckchem.com/pr....oducts/cd38-inhibito
To the best of our knowledge, this has been the first study to report that pembrolizumab administration before surgery for chemotherapy-resistant ureteral carcinoma promoted a pathological complete response, providing a better understanding of the cancer microenvironment after immunotherapy.Background To investigate the prognostic role of tumor size in patients with pathological T2N0M0 and T3aN0M0 renal cell carcinoma (RCC) treated by radical surgery. Methods A total of 3,662 cases were retrospectively analyzed from the Surveil
Like
Comment
Share
